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Cyclosporine toxicity in renal transplant recipients detected by Indeed, cyclosporine constitutes a major advance in the
nailfold capillaroscopy with Na-fluorescein. medical management of organ transplantation. How-
Background. Cyclosporine represented a major advance in ever, its use is restricted by the occurrence of arterialthe medical management of patients with organ transplanta-
hypertension and renal toxicity in a substantial propor-tion, but its use is limited by the frequent occurrence of hyper-
tion of patients [1–4]. The diagnosis is made by renaltension and renal toxicity diagnosed by invasive renal biopsy.
Renal histology shows a specific arteriolopathy. It was hypothe- biopsy. Histology characteristically shows a necrosis of
sized that cyclosporine may also induce subclinical microvascu- the arteriolar myocytes [3]. With time, interstitial fibrosis
lar changes in the skin that might be detected noninvasively
develops, and the lesions become irreversible. This neph-by a combination of dynamic capillaroscopy [capillary blood
rotoxicity seems to be directly related to cyclosporinecell velocity (CBV)] with and without intravenous Na-fluores-
cein (NaF) injection and laser Doppler fluxmetry (LDF). with a dose-dependent effect. However, the exact mecha-
Methods. The nailfold skin microcirculation was evaluated nisms of the toxicity remain unknown [4], although sev-
in 112 consecutive renal transplant recipients (54 6 11 years
eral studies suggest a relationship between the toxicityold; 70 males and 42 females) receiving cyclosporine. The inves-
and the plasma endothelin [5–9]. On the other hand, thetigation was made the same day as a routine renal biopsy per-
formed in all patients more than two years after transplantation. safety of percutaneous renal biopsy has been improved
Renal biopsies were blindly classified as positive (N 5 33) by the use of automated biopsy guns, but the procedure
when significant specific signs of cyclosporine toxicity were remains invasive and is still associated with a major com-
clearly observed (AH2–AH3) and were otherwise negative
plication rate of up to 3.4% [10]. It was consequently(AH0–AH1, N 5 79) according to the Banff classification.
tempting to develop a simpler and less invasive test forResults. Time to fluorescence peak after NaF injection (tpNaF)
was significantly longer in patients with positive biopsies than screening for cyclosporine toxicity. Thus, it was hypothe-
in patients with negative biopsies (13.9 6 8.1 vs. 17.5 6 9.4 sized that cyclosporine may also induce subclinical mi-
sec, P 5 0.009). All patients but three with negative biopsies crovascular changes in the skin that might be detected(93%) had a tpNaF less than 10 seconds (sensitivity 91%, negative
by dynamic capillaroscopy. Capillaroscopy provides apredictive value 93%). On the other hand, CBV, LDF, plasma
simple and noninvasive means to evaluate skin microcir-levels of cyclosporine, and endothelin were similar in the two
groups. culation [11–13]. Since the mid-1970s, the technique has
Conclusion. Nailfold fluorescence capillaroscopy is an accu- been progressively sophisticated using computers to per-
rate and simple mean to rule out cyclosporine toxicity in renal
form dynamic measurements of the blood flow in skintransplant recipients. A normal test could avoid invasive renal
capillaries [12, 13]. The performance of the techniquebiopsy in about 40% of the patients. Renal biopsy would,
however, still be indicated when the test is abnormal. has been further improved by the use of an intravenous
injection of Na-fluorescein (NaF), a small molecule that
fluoresces in the visible spectrum and greatly enhances
Vascular toxicity may complicate several drug thera- the possibilities of conventional capillaroscopy. Indeed,
pies. Among them, cyclosporine arouses special interest.
its sensitivity regarding the detection of morphological
changes in the nutritional circulation is definitely im-
proved by enhancing the image contrast and providingKey words: renal graft, skin microcirculation, dynamic capillaroscopy,
laser Doppler fluxmetry. an assessment of microvascular flow distribution and a
dynamic evaluation of transcapillary and interstitial dif-
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Fig. 1. Capillaroscopy without (A) and with
intravenous Na-fluorescein (NaF) injection (B).
NaF greatly improves the sensitivity of capil-
laroscopy by enhancing the image contrast
and providing an assessment of microvascular
flow distribution and a dynamic evaluation of
transcapillary and interstitial diffusion of dye
in the interstitium.
means of the combination of dynamic capillaroscopy and Macrocirculation
laser Doppler fluxmetry (LDF) with and without intrave- Arm and finger systolic blood pressures (SBP) were
nous injection of NaF, to detect cyclosporine toxicity in measured with a 14 cm wide cuff and a mercury manome-
renal transplant recipients, using renal biopsies as the ter. Stethoscopic method was used at arm and Doppler
gold standard. at ankle (Parks Electronic model 1010). Finger SBP was
measured with a miniature plastic 2.4 cm wide cuff placed
at the basis of the proximal phalanx of the studied fingerMETHODS
and laser Doppler technique [9].One hundred twelve consecutive renal transplant re-
cipients treated with cyclosporine with a transplantation Microcirculation
older than two years were admitted in our hospital for
Dynamic capillaroscopy. The method has been de-a routine renal biopsy and were included in the study.
scribed in detail elsewhere [11, 18]. Briefly, the capillariesThey underwent an investigation of the skin microcircu-
of the nailfold of the investigated finger were displayedlation on the day of biopsy. Typical medical therapy of
on a television monitor by means of a Leitz epi-micro-the patients consisted of an association of immunosu-
scope connected to a television camera with a final mag-pressive drugs (cyclosporine, azathioprine, prednisone)
nification of 3950. The capillary blood cell velocityand one or more antihypertensive drug (nifedepine,
(CBV) was measured in single capillaries by a videopho-atenolol, enalapril, labetalol, clonidine). Twenty-one pa-
tometric technique using a computerized system (Capi-tients were diabetics receiving insulin or oral treatment,
Flowt; CapiFlow AB, Kista, Sweden) [19]. Two photo-and only four patients were smokers. The study protocol
metric windows were generated by the computer andwas approved by the Ethics Committee of the Depart-
placed along the arteriolar limb of the investigated capil-ment of Internal Medicine of our institution and written
lary. The videodensitometric signals of the windows wereinformed consent was obtained from all patients.
cross-correlated, and the interwindow transit time for
similar signals was determined. With a known interwin-Biological parameters
dow distance, the CBV can be continuously calculated,Plasma levels of endothelin were measured the day
displayed on the computer screen, and registered.of renal biopsy. Plasma levels of urea, creatinine, and
Dynamic capillaroscopy with dye (Na-fluorescein). Bycyclosporine were measured at the last medical visit pre-
means of a fluorescence filter set, a video timer, and aceding the renal biopsy (7 to 135 days before renal
video scale maker, dynamic capillaroscopy can be adaptedbiopsy, median 50 days). No cyclosporine dose adjust-
to study the diffusion of NaF through the capillary wall inment was made during this period.
the interstitial space. NaF is a small molecule (molecular
Renal biopsies weight of 376) that is partially bound to plasma (40%)
and fluoresces in the visible part of the spectrum. NaFAll renal biopsies were performed using an automated
was injected into an antecubital vein as a bolus (,2 sec)biopsy gun [10]. All biopsies were analyzed in a blinded
comprising 1 to 1.5 mL of 20% NaF (0.2 to 0.3 mL/Lfashion by the same experienced pathologist (Dr. R.
estimated individual blood volume) and 5 to 10 mL ofLemoine), and the signs of cyclosporine toxicity were
physiologic saline solution were given immediately after-scored in four stages (AH0 to AH3) according to the
ward in order to enhance flow of dye toward thoracicBanff classification [17]. According to clinical relevance,
vessels [14–16]. The capillary scene was continuouslythe biopsies were further classified as positive when sig-
recorded for four minutes from the time of NaF injectionnificant signs of cyclosporine toxicity (AH2 1 AH3)
for further analysis. Transcapillary diffusion of NaF inwere present and led to a decrease of cyclosporine dose
and as negative when absent (AH0 1 AH1). the interstitium, depicting the pericapillary halo and flu-
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orescence intensity, was analyzed by densitometry using pertension, or medical treatment between patients with
the CapiFlowt system [19]. The appearance time, that or without significant histologic signs of cyclosporine tox-
is, the time interval between the end of dye injection icity. Both daily dose and plasmatic levels of cyclosporine
and first arrival of in the field of observation and the were similar in the two groups. Furthermore, no differ-
time to peak fluorescence intensity was measured by ence was observed in the endothelin plasma levels.
means of the video timer. The fluorescence intensity
Macrocirculationwas expressed in percentage of the background intensity
before dye appearance. Since anaphylactoid reactions No difference was observed in arm and finger SBPs
have been exceptionally described with the use of NaF, between patients with and without cyclosporine toxicity.
resuscitation equipment was available during the period
of examination. Microcirculation
Laser Doppler fluxmetry. The LDF was measured No significant difference was observed both at rest
close to the investigated nailfold area by means of a laser and during postocclusive reactive hyperhemia in the total
Doppler fluxmeter (MBF3Dt, Moor, UK). The LDF skin microcirculation, that is, the LDF, or in the nutri-
signal (time constant 0.5 sec) was displayed on a chart tional microcirculation, that is, CBV, between the pa-
recorder, and the LDF values were automatically aver- tients with and without cyclosporine toxicity.
aged by the fluxmeter. Mean LDF values are expressed A large difference was, however, observed between
in arbitrary units (AUs). An arterial occlusion was per- the two groups using the NaF. The time to peak intensity
formed by inflating a miniature cuff placed at the base
of NaF was significantly (P , 0.009) delayed in patients
of the investigated toe to determine the residual LDF
with significant histologic signs of cyclosporine toxicityvalue (biological zero), which was subsequently sub-
(AH2–AH3) as compared with those without toxicitytracted from all LDF values.
(AH0–AH1; Fig. 2). All patients without cyclosporineSkin temperature. The skin temperature was continu-
toxicity except three (93%) had a time to peak NaFously recorded in the investigated area with a thermistor.
shorter than 10 seconds (P , 0.0001).The room temperature was kept between 24.9 and 26.58C
and varied by less than 0.58C during a given examination.
Investigation procedure. Patients were resting com- DISCUSSION
fortably in sitting position for 20 minutes before the
The present study showed an excellent correlation be-measurements started. The few smokers were asked not
tween histologic signs of cyclosporine toxicity on routineto smoke at least two hours before the investigation. The
renal biopsies in renal transplant recipients treated withfourth left finger was positioned on the microscope stage
cyclosporine and hemodynamic abnormalities in thewith the hand at the heart level. A miniature 2.4 cm cuff
nailfold microvessels as detected by dynamic capillaros-was left at the basis of the investigated finger to perform
copy with intravenous NaF injection. This finding is impor-arterial occlusion (200 mm Hg). Resting skin tempera-
tant because the prevalence of cyclosporine nephropathyture, CBV, and LDF were measured for three minutes,
is much higher than previously suspected in asymptom-after which an arterial occlusion was performed. The
atic patients. Thirty percent of the patients in our seriescuff was released after one minute, and CBV and LDF
had significant histologic signs of cyclosporine toxicitywere measured for two minutes during postocclusive re-
active hyperemia response. The fluorescence filter was (score AH2–AH3 according to the Banff classification)
then inserted in the microscope, and the NaF was in- [17], which led to a reduction of cyclosporine dose. The
jected after both CBV and LDF had returned to baseline results of the present study fully support the view that
values. The nailfold scene was recorded for four minutes cyclosporine also induces infraclinical microvascular
after intravenous NaF injection. Arm and finger SBP changes in the skin that may be detected by dynamic
were measured at the end of the investigation. capillaroscopy with dye injection.
The circulation speed of the dye in the skin microcircu-Statistical analysis
lation, expressed as the time between appearance and
Values are expressed as mean 6 SD unless stated peak intensity of the fluorescence, was significantly (P ,
otherwise. The Student’s t-test and the Mann–Whitney 0.009) delayed in patients with cyclosporine toxicity as
U-test (two-tailed) and chi-square tests were used for compared with those without. Thus, all patients but three
statistical analysis, when appropriate. A P value of less (93%) without cyclosporine nephrotoxicity had a time
than 0.05 was considered significant.
to peak fluorescence intensity of shorter than 10 seconds.
Using this cutoff value for the normal range, the test
RESULTS has both a very good sensitivity (91%) and negative
predictive value (93%) to rule out cyclosporine toxicity.Patient characteristics are displayed in Table 1. There
was no significant difference in diabetes prevalence, hy- The specificity of the test is, however, poor (45%) and a
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Table 1. Comparison between plasmatic, macro- and microcirculatory data and histologic signs
of cyclosporine toxicity in 112 renal graft recipients
Histologic signs of cyclosporine toxicity
Absent (AH0–AH1) N 5 79 Present (AH2–AH3) N 5 33 P
Cyclosporine
Daily cyclosporine dose mg/day/kg 2.660.9 2.360.6 NS
Cyclosporinemia lg/L 89636 87643 NS
Urea mmol/L 7.461.8 8.262.5 NS
Creatinine lmol/L 110622 128633 ,0.002
Macrocirculation
Arm systolic blood pressure mm Hg 139616 142614 NS
Finger systolic blood pressure mm Hg 116619 118621 NS
Microcirculation at rest
Skin temperature 8C 29.264.0 29.562.9 NS
Blood cell capillary velocity (CBV) mm/sec 0.3960.31 0.4260.36 NS
Laser Doppler flux (LDF) AU 58657 77681 NS
Microcirculation during reactive hyperhemia
Peak CBV mm/sec 0.960.52 1.060.5 NS
Time to peak CBV sec 7.363.2 7.961.5 NS
Peak LDF AU 132697 1596122 NS
Time to peak LDF sec 5.462.1 5.961.7 NS
Capillaroscopy with IV fluorescein
Peak fluorescein intensity % 3306108 3626105 NS
Time to peak fluorescein intensitya sec 13.968.1 17.569.4 ,0.009
Halo diameter % of the capillary loop 50611 5667 NS
Plasma levels of endothelin
Endothelin pg/mL 2.7260.57 2.8460.86 NS
a The time to peak intensity is the time from first appearance of the dye in the capillaries to its peak intensity
renal biopsy remains indicated when the test is abnormal
(.10 sec).
The delayed time to peak intensity of the fluorescence
in the skin microcirculation in patients with cyclosporine
nephrotoxicity may be explained by both functional and
structural factors. On one hand, cyclosporine exerts di-
rect vasoconstrictive effects on the endothelium and the
microvasculature that may reduce the blood flow in the
microcirculation [1, 2, 4, 20]. On the other hand, cyclospo-
rine induces a specific arteriolopathy that is characterized
by eosinophilic granular transformation of vascular smooth
muscle cells of afferent glomerular arterioles that may
progress to necrosis of individual muscle cells and hyalin-
ization of the vessel wall [3]. These factors would lead
to decrease the blood flow in the arterioles of the skin
as it does in the kidney [3, 4], and consequently also
downstream in the capillaries, resulting in a decrease of
the circulation speed of the dye in the microcirculation
and thus to delayed fluorescence peak intensity. A sig-
nificant influence of macrocirculatory factors in that phe-
nomenon seems unlikely since the circulation time of
the dye in the macrocirculation, that is, the time from
intravenous injection to appearance in the nailfold, was
subtracted from the time to peak NaF intensity. Surpris-
ingly, no difference was observed in the diffusion pat-
terns of the dye in the interstitium between patientsFig. 2. Time to peak of intensity of the NaF in patients with and without
significant histologic signs of cyclosporine toxicity. The macrocirculatory with and without cyclosporine toxicity. In particular, the
component, that is, the time from intravenous injection to first dye pericapillar halo was very similar in both groups, which
appearance in the nailfold capillaries, has been subtracted. A short time
suggests that the transcapillary diffusion of the dye wasto peak NaF (,10 sec) was associated with normal kidney biopsies in
42 of 45 patients (93%, P , 0.0001, chi-squared). not significantly altered by cyclosporine.
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